RNTX
Rein Therapeutics
RNTX
RNTX
19 hedge funds and large institutions have $1.3M invested in Rein Therapeutics in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6.74% less ownership
Funds ownership: 29.89% → 23.14% (-6.7%)
59% less capital invested
Capital invested by funds: $3.21M → $1.3M (-$1.91M)
Holders
19
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$24K | |
| 2 | +$14K | |
| 3 | +$12.9K | |
| 4 |
Renaissance Technologies
New York
|
+$2.65K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.1K |
Top Sellers
| 1 | -$561K | |
| 2 | -$88.3K | |
| 3 | -$44.2K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.98K |